|
1
|
Matsuda T and Saika K: Worldwide burden of
cancer incidence in 2002 extrapolated from cancer incidence in five
continents Vol.IX. Jpn J Clin Oncol. 42:1111–1112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo LL, Song CH, Wang P, Dai LP, Zhang JY
and Wang KJ: Competing endogenous RNA networks and gastric cancer.
World J Gastroenterol. 21:11680–11687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J, Huang CM, Zheng CH, Li P, Xie JW,
Wang JB and Lin JX: Consideration of tumor size improves the
accuracy of TNM predictions in patients with gastric cancer after
curative gastrectomy. Surg Oncol. 22:167–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Müller S, Raulefs S, Bruns P, Afonso-Grunz
F, Plötner A, Thermann R, Jäger C, Schlitter AM, Kong B, Regel I,
et al: Next-generation sequencing reveals novel differentially
regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic
cancer. Mol Cancer. 14:942015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Müller S, Raulefs S, Bruns P, Afonso-Grunz
F, Plötner A, Thermann R, Jäger C, Schlitter AM, Kong B, Regel I,
et al: Erratum to: Next-generation sequencing reveals novel
differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA
in pancreatic cancer. Mol Cancer. 14:1442015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao T, Xu J, Liu L, Bai J, Xu C, Xiao Y,
Li X and Zhang L: Identification of cancer-related lncRNAs through
integrating genome, regulome and transcriptome features. Mol
Biosyst. 11:126–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu Y, Chen T, Li G, Yu X, Lu Y, Wang H and
Teng L: LncRNAs: Emerging biomarkers in gastric cancer. Future
Oncol. 11:2427–2441. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang X, Zhi X, Gao Y, Ta N, Jiang H and
Zheng J: LncRNAs in pancreatic cancer. Oncotarget. 30:57379–57390.
2016.
|
|
11
|
Jonsson P, Coarfa C, Mesmar F, Raz T,
Rajapakshe K, Thompson JF, Gunaratne PH and Williams C:
Single-molecule sequencing reveals estrogen-regulated clinically
relevant lncRNAs in breast cancer. Mol Endocrinol. 29:1634–1645.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng L, Yuan X, Jiang B, Tang Z and Li GC:
LncRNAs: Key players and novel insights into cervical cancer.
Tumour Biol. 37:2779–2788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ali Z, Deng Y, Tang Y, Zheng S, Ma N and
He N: Epigenetic deregulations in gastric cancer. J Nanosci
Nanotechnol. 13:40–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hildmann C, Riester D and Schwienhorst A:
Histone deacetylases-an important class of cellular regulators with
a variety of functions. Appl Microbiol Biotechnol. 75:487–497.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mithraprabhu S, Kalff A, Chow A, Khong T
and Spencer A: Dysregulated class I histone deacetylases are
indicators of poor prognosis in multiple myeloma. Epigenetics.
9:1511–1520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christensen DP, Dahllöf M, Lundh M,
Rasmussen DN, Nielsen MD, Billestrup N, Grunnet LG and
Mandrup-Poulsen T: Histone deacetylase (HDAC) inhibition as a novel
treatment for diabetes mellitus. Mol Med. 17:378–390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mutze K, Langer R, Becker K, Ott K,
Novotny A, Luber B, Hapfelmeier A, Göttlicher M, Höfler H and
Keller G: Histone deacetylase (HDAC) 1 and 2 expression and
chemotherapy in gastric cancer. Ann Surg Oncol. 17:3336–3343. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Z, Zhou L, Wu LM, Xie HY, Zhang F and
Zheng SS: Combination of polymorphisms within the HDAC1 and HDAC3
gene predict tumor recurrence in hepatocellular carcinoma patients
that have undergone transplant therapy. Clin Chem Lab Med.
48:1785–1791. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wan QS and Zhang KH: Noninvasive detection
of gastric cancer. Tumour Biol. 37:11633–11643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gigek CO, Chen ES, Calcagno DQ, Wisnieski
F, Burbano RR and Smith MA: Epigenetic mechanisms in gastric
cancer. Epigenomics. 4:279–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hagelkruys A, Sawicka A, Rennmayr M and
Seiser C: The biology of HDAC in cancer: The nuclear and epigenetic
components. Handb Exp Pharmacol. 206:13–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang YN, Zhang K, Hu ZM, Qi HX, Shi ZM,
Han XH, Han YW and Hong W: Hypoxia-regulated lncRNAs in cancer.
Gene. 575:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao B, Song N, Zhang M, Di C, Yang Y, Lu
Y, Chen R, Lu ZJ and Guo M: Systematic study of novel lncRNAs in
different gastrointestinal cancer cells. Discov Med. 21:159–171.
2016.PubMed/NCBI
|
|
25
|
Cheng WS, Tao H, Hu EP, Liu S, Cai HR, Tao
XL, Zhang L, Mao JJ and Yan DL: Both genes and lncRNAs can be used
as biomarkers of prostate cancer by using high throughput
sequencing data. Eur Rev Med Pharmacol Sci. 18:3504–3510.
2014.PubMed/NCBI
|
|
26
|
Cogill SB and Wang L: Co-expression
network analysis of human lncRNAs and cancer genes. Cancer Inform.
13 (Suppl 5):S49–S59. 2014.
|
|
27
|
Han J, Rong LF, Shi CB, Dong XG, Wang J,
Wang BL, Wen H and He ZY: Screening of lymph nodes metastasis
associated lncRNAs in colorectal cancer patients. World J
Gastroenterol. 20:8139–8150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang F, Zhang L and Zhang C: Long
noncoding RNAs and tumorigenesis: Genetic associations, molecular
mechanisms, and therapeutic strategies. Tumour Biol. 37:163–175.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fayda M, Isin M, Tambas M, Guveli M, Meral
R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, et al: Do
circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5,
HOTAIR) predict the treatment response in patients with head and
neck cancer treated with chemoradiotherapy? Tumour Biol.
37:3969–3978. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seto E and Yoshida M: Erasers of histone
acetylation: The histone deacetylase enzymes. Cold Spring Harb
Perspect Biol. 6:a0187132014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Terui Y: The epigenetic alteration and the
effect of HDAC inhibitors in multiple myeloma. Nihon Rinsho.
73:124–129. 2015.(In Japanese). PubMed/NCBI
|
|
32
|
Srinivas C, Swathi V, Priyanka C, Anjana
Devi T, Subba Reddy BV, Janaki Ramaiah M, Bhadra U and Bhadra MP:
Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate
the expression of microRNAs in hepatocellular carcinoma. Apoptosis.
21:1249–1264. 2016. View Article : Google Scholar : PubMed/NCBI
|
